194 related articles for article (PubMed ID: 37712178)
1. Intratumoral Bacteria as Mediators of Cancer Immunotherapy Response.
Sfanos KS
Cancer Res; 2023 Sep; 83(18):2985-2986. PubMed ID: 37712178
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral Microbiota Composition Regulates Chemoimmunotherapy Response in Esophageal Squamous Cell Carcinoma.
Wu H; Leng X; Liu Q; Mao T; Jiang T; Liu Y; Li F; Cao C; Fan J; Chen L; Chen Y; Yao Q; Lu S; Liang R; Hu L; Liu M; Wan Y; Li Z; Peng J; Luo Q; Zhou H; Yin J; Xu K; Lan M; Peng X; Lan H; Li G; Han Y; Zhang X; Xiao ZJ; Lang J; Wang G; Xu C
Cancer Res; 2023 Sep; 83(18):3131-3144. PubMed ID: 37433041
[TBL] [Abstract][Full Text] [Related]
3. Microbiome bacterial influencers of host immunity and response to immunotherapy.
Yousefi Y; Baines KJ; Maleki Vareki S
Cell Rep Med; 2024 Apr; 5(4):101487. PubMed ID: 38547865
[TBL] [Abstract][Full Text] [Related]
4. Alterations in gut microbiota of esophageal squamous cell carcinoma patients.
Cheung MK; Yue GGL; Lauw S; Li CSY; Yung MY; Ng SC; Yip HC; Kwan HS; Chiu PWY; Lau CBS
J Gastroenterol Hepatol; 2022 Oct; 37(10):1919-1927. PubMed ID: 35816164
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies.
Lu Y; Yuan X; Wang M; He Z; Li H; Wang J; Li Q
J Hematol Oncol; 2022 Apr; 15(1):47. PubMed ID: 35488243
[TBL] [Abstract][Full Text] [Related]
6. Current status of intratumour microbiome in cancer and engineered exogenous microbiota as a promising therapeutic strategy.
Chen J; Li T; Liang J; Huang Q; Huang JD; Ke Y; Sun H
Biomed Pharmacother; 2022 Jan; 145():112443. PubMed ID: 34847476
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiome homeostasis and the future of probiotics in cancer immunotherapy.
Singh A; Alexander SG; Martin S
Front Immunol; 2023; 14():1114499. PubMed ID: 37261348
[TBL] [Abstract][Full Text] [Related]
8. Gut Microbiota and Antitumor Immunity: Potential Mechanisms for Clinical Effect.
Baruch EN; Wang J; Wargo JA
Cancer Immunol Res; 2021 Apr; 9(4):365-370. PubMed ID: 34003768
[TBL] [Abstract][Full Text] [Related]
9. The Impact of the Microbiome on Resistance to Cancer Treatment with Chemotherapeutic Agents and Immunotherapy.
Sevcikova A; Izoldova N; Stevurkova V; Kasperova B; Chovanec M; Ciernikova S; Mego M
Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008915
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy for Pancreatic Cancer: More Than Just a Gut Feeling.
Riquelme E; Maitra A; McAllister F
Cancer Discov; 2018 Apr; 8(4):386-388. PubMed ID: 29610286
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Intratumoral and Gastrointestinal Microbiota on Systemic Cancer Therapy.
Cogdill AP; Gaudreau PO; Arora R; Gopalakrishnan V; Wargo JA
Trends Immunol; 2018 Nov; 39(11):900-920. PubMed ID: 30392721
[TBL] [Abstract][Full Text] [Related]
12. Crosstalk between the gut microbiome and clinical response in locally advanced thoracic esophageal squamous cell carcinoma during neoadjuvant camrelizumab and chemotherapy.
Xu L; Qi Y; Jiang Y; Ji Y; Zhao Q; Wu J; Lu W; Wang Y; Chen Q; Wang C
Ann Transl Med; 2022 Mar; 10(6):325. PubMed ID: 35433940
[TBL] [Abstract][Full Text] [Related]
13. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.
Zhang SL; Mao YQ; Zhang ZY; Li ZM; Kong CY; Chen HL; Cai PR; Han B; Ye T; Wang LS
Theranostics; 2021; 11(9):4155-4170. PubMed ID: 33754054
[No Abstract] [Full Text] [Related]
14. Influence of Microbiota on Tumor Immunotherapy.
Yu X; Li W; Li Z; Wu Q; Sun S
Int J Biol Sci; 2024; 20(6):2264-2294. PubMed ID: 38617537
[TBL] [Abstract][Full Text] [Related]
15. Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy.
Wu J; Wang S; Zheng B; Qiu X; Wang H; Chen L
Front Immunol; 2021; 12():669150. PubMed ID: 34267748
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral microbiota: implications for cancer onset, progression, and therapy.
Wu J; Zhang P; Mei W; Zeng C
Front Immunol; 2023; 14():1301506. PubMed ID: 38292482
[TBL] [Abstract][Full Text] [Related]
17. The Species of Gut Bacteria Associated with Antitumor Immunity in Cancer Therapy.
Qi X; Liu Y; Hussein S; Choi G; Kimchi ET; Staveley-O'Carroll KF; Li G
Cells; 2022 Nov; 11(22):. PubMed ID: 36429112
[TBL] [Abstract][Full Text] [Related]
18. Gut Microbiota in Cancer Immune Response and Immunotherapy.
Zhou CB; Zhou YL; Fang JY
Trends Cancer; 2021 Jul; 7(7):647-660. PubMed ID: 33674230
[TBL] [Abstract][Full Text] [Related]
19. Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy.
Qiu Q; Lin Y; Ma Y; Li X; Liang J; Chen Z; Liu K; Huang Y; Luo H; Huang R; Luo L
Front Immunol; 2020; 11():612202. PubMed ID: 33488618
[TBL] [Abstract][Full Text] [Related]
20. Intratumoral microbiota: new frontiers in tumor immunity.
Zhang Z; Liao Y; Tang D
Carcinogenesis; 2022 Sep; 43(8):719-727. PubMed ID: 35868230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
